a-synuclein PET Imaging: From Clinical Utility in Multiple System Atrophy to the Possible Diagnosis of Parkinson’s Disease

The development of PET tracers for the detection of pathological alpha-synuclein (a-synuclein) has the potential to revolutionize the diagnosis, monitoring, and therapeutic interventions of synucleinopathies, including Parkinson’s disease. The journey toward identifying effective PET imaging agents,...

Full description

Bibliographic Details
Published in:Cells
Main Author: Francesca Capotosti
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/11/834